Seelos Therapeutics (SEEL) Prices 7.5M Share Common Offering at $0.60/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- US stock index futures slip as high-stakes Iran, inflation tests loom
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
Seelos Therapeutics (SEEL) Announces Proposed Public Offering of Common Stock
March 11, 2020 4:15 PM EDTSeelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today that it has commenced a proposed underwritten public offering of shares of common stock. The offering is subject... More
Seelos Therapeutics (SEEL) Announces EMA Guidance to Design Open-Label Pivotal Study for SLS-005 in Sanfilippo Syndrome
March 11, 2020 8:11 AM EDTSeelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced that it has received a written response from the European Medicines Agency (EMA), in lieu of a face to face... More
